This inventor holds 10 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Prism Biolab Co., Ltd., Prism Pharma Co., Ltd., Prism Biolab Corporation. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (2017 - 2019)
- Yokohama, JP (2013 - 2022)
Company Filing History:
4 out of 4 
4 out of 5 
2 out of 3 
Years Active: 2013-2022
Title: The Innovative Mind of Takenao Odagami
Introduction
Takenao Odagami is a notable inventor based in Yokohama, Japan, recognized for his substantial contributions to the field of biomedical research. With an impressive portfolio of 10 patents, Odagami is dedicated to developing innovative therapeutic drugs to combat cancer and other severe health conditions. His work has the potential to significantly improve treatment outcomes for patients worldwide.
Latest Patents
Among Odagami's latest patents is a revolutionary anticancer combination involving a CBP/catenin inhibitor and an immune checkpoint inhibitor. This invention focuses on creating a therapeutic drug for cancer that exhibits a superior treatment effect. The combination not only enhances the treatment efficacy on cancer but also offers an effective solution for patients who have shown low sensitivity to immune checkpoint inhibitors when used alone. Another significant patent addresses the prevention or treatment of hepatic fibrosis, demonstrating that the CBP/β-catenin inhibitor exhibits a substantial defibrosing effect in an animal model. This groundbreaking research opens new avenues for the prophylactic and therapeutic treatment of hepatic fibrosis.
Career Highlights
Throughout his career, Takenao Odagami has worked with renowned organizations such as Prism Pharma Co., Ltd. and Prism Biolab Co., Ltd. His role within these companies has allowed him to focus on the advancement of therapeutic interventions and has contributed to his success as an inventor. His dedication to scientific innovation is reflected in the numerous patents he holds, which showcase his commitment to improving healthcare.
Collaborations
Odagami has collaborated with talented individuals, including Hiroyuki Kouji and Yuji Kogami. These partnerships have fostered a creative environment, resulting in the development of groundbreaking solutions to complex medical challenges. Together, they have combined their expertise to push boundaries and explore innovative approaches in biomedical research.
Conclusion
Takenao Odagami's journey as an inventor highlights his passion and commitment to advancing medical science through innovative inventions. His latest patents not only provide promising therapeutic options for cancer and hepatic fibrosis but also exemplify the power of collaboration in research. As he continues to expand his portfolio, Odagami remains a significant figure in the realm of biomedical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile